Assessment of Radioembolization Treatment Response: Standardization, Tips & Tricks
Journal Title: Nükleer Tıp Seminerleri - Year 2019, Vol 5, Issue 2
Abstract
Different guidelines are used to assess the response to contemporary radioembolization treatment. Nonetheless, striking heterogeneity of patients and especially tumors larger than 5 cm or infiltrative in nature may pose tremendous problems. Moreover, radiation effects on imaging in early stages complicate confirmation of local recurrences/residual tumor. Therefore, multidisciplinary approach that will take into account the patient’s pre-/post-treatment radiological and laboratory data is indispensable. In this review, our personal experience on evaluation of radioembolization treatment response is discussed in the light of data based on literature.
Authors and Affiliations
Abdullah Yakupoğlu
Nuclear Cardiology in Asymptomatic Patients
One of the most important causes of death is still myocardial ischemia which is caused by myocardial oxygen demand not supplied by coronary blood flow due to coronary artery disease in increased workload conditions. Stab...
Positron Emission Tomography/Magnetic Resonanse Imaging Applications in Neurologic Imaging
Hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) systems allow simultaneous assessment of disease-related structural and functional changes that occur in neurological disorders. Diagnostic use of...
Sentinel Lymph Node Biopsy for Gastrointestinal Cancers
In the treatment of gastrointestinal cancer (GIC), the exact assessment of the lymph node status is the most important factor in determining the clinical outcome of patients. The benefit of sentinel lymph node imaging in...
Radiation Detection and Measurement
Radiation is not a phenomenon that can be sensed, it is invisible, inaudible, imperceptible, and it cannot be perceived by contact. In cases of diagnosis, treatment, radiation protection, and possible radiation accidents...
Radioembolization: Patient Selection and Planning
Transarterial radioembolization (TARE) with yttrium-90 (Y-90)-labeled microspheres has shown promising results in the treatment of patients with unresectable primary and metastatic liver cancer in the last 10 years. Whil...